ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

UHS Umuthi Healthcare Solutions Plc

35.00
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Umuthi Healthcare Solutions Plc LSE:UHS London Ordinary Share GB00BJ56HG01 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 35.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Umuthi Healthcare Soluti... Share Discussion Threads

Chat Pages: 1
DateSubjectAuthorDiscuss
21/6/2021
10:48
Back on wed hxxps://www.howwemadeitinafrica.com/africas-shot-at-local-pharma-production/118032/

Right time right place...

bobbie870
02/6/2021
10:15
Made an initial purchase today
w1lbur01
08/4/2021
15:04
Any second now ..........
themanwhofelltoearth
12/3/2021
09:42
Just LOL!Now suspended.How the FCA could allow a company to list that faces a winding up order & according to Companies House is overdue with its accounts defies belief.I gather it has other "problems".
1tx
08/3/2021
17:40
(Alliance News) - Umuthi Healthcare Solutions PLC was on Thursday admitted to trading on the London Stock Exchange's Main Market.

Umuthi is a technology-led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas.

Umuthi kicked off its dealings on Thursday morning, with 92 million shares in issue at 30.00 pence each.

Umuthi currently has its main operations, operating through subsidiary Lems, in South Africa but is looking to expand organically and by way of acquisition in Africa and Europe.

"This is possible due to the low-risk business model being ideal for the current global environment caused by the Covid-19 pandemic," the company said.

"Whilst operating in a highly regulated environment and due to South Africa having clusters of highly developed cities and expansive rural areas, general practitioners are required to dispense medicines from their consulting rooms. Large pharmaceutical companies are not permitted to transact with GP's directly, therein giving an opportunity for companies such as Umuthi to provide the warehousing and distribution capabilities to GP's," the company added.

Umuthi is in discussions to distribute Covid-19 vaccines and related products via its distribution and warehousing capabilities.

knowing
08/3/2021
17:38
could be interesting
inv
Chat Pages: 1

Your Recent History

Delayed Upgrade Clock